GH
ONCE

GAM Holding’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

GAM Holding’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,970
Closed -$3.07M – 969
2019
Q1 		$3.07M Buy
+26,970
New +$1.98M 0.13% 186
2017
Q1 		– Sell
-32,900
Closed -$1.64M – 1107
2016
Q4 		$1.64M Buy
32,900
+21,700
+194% +$1.16M 0.03% 534
2016
Q3 		$673K Buy
+11,200
New +$646K 0.01% 671

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

GAM Holding's ONCE Position: Q2 2019 in Review

GAM Holding sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 26,970 shares — an estimated $3.07M sold.

GAM Holding first reported a position in ONCE in Q3 2016 and held it in 3 quarters. The position peaked at $3.07M in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • GAM Holding reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • GAM Holding sold 26,970 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $3.07M.
  • GAM Holding first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2016 and held it in 3 quarters.
  • GAM Holding's Spark Therapeutics, Inc. Common Stock position peaked at $3.07M in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on GAM Holding's 13F filing for Q2 2019, filed 12 Aug 2019.